MwanzoBIOG-B • STO
add
BioGaia AB
Bei iliyotangulia
kr 122.50
Bei za siku
kr 120.30 - kr 124.00
Bei za mwaka
kr 93.20 - kr 124.00
Thamani ya kampuni katika soko
12.07B SEK
Wastani wa hisa zilizouzwa
elfu 211.80
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 440.57M | 20.76% |
Matumizi ya uendeshaji wa biashara | 196.47M | 69.09% |
Mapato halisi | 98.78M | 20.56% |
Kiwango cha faida halisi | 22.42 | -0.18% |
Mapato kwa kila hisa | 0.98 | — |
EBITDA | 133.49M | -10.77% |
Asilimia ya kodi ya mapato | 20.07% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 801.31M | -34.53% |
Jumla ya mali | 1.60B | -21.45% |
Jumla ya dhima | 283.59M | -8.54% |
Jumla ya hisa | 1.31B | — |
hisa zilizosalia | 101.16M | — |
Uwiano wa bei na thamani | 9.43 | — |
Faida inayotokana na mali | 20.64% | — |
Faida inayotokana mtaji | 24.92% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 98.78M | 20.56% |
Pesa kutokana na shughuli | 83.52M | -18.23% |
Pesa kutokana na uwekezaji | elfu -452.00 | -79.37% |
Pesa kutokana na ufadhili | -6.61M | -160.38% |
Mabadiliko halisi ya pesa taslimu | 73.21M | -33.07% |
Mtiririko huru wa pesa | 53.30M | 13.33% |
Kuhusu
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1990
Tovuti
Wafanyakazi
242
